Could the secret to silencing addiction be hiding in a Gila monster's saliva?
In short: Physician Dhruv Khullar examines how GLP-1 medications like Ozempic might extend their reach beyond diabetes management. By investigating their impact on the brain, this talk explores whether these drugs can effectively quiet the persistent noise of cravings and serve as a novel treatment for addiction.
Originally identified in the saliva of the Gila monster, GLP-1 receptor agonists have evolved from a diabetes treatment into a subject of intense medical interest. While these drugs are famous for their metabolic effects, their most significant potential may lie in their ability to influence neural pathways.
Dhruv Khullar discusses the journey of these 'moderation molecules' and their capacity to potentially dampen the intense urges associated with addictive behaviors. By shifting the focus from the gut to the brain, researchers are investigating whether these medications can fundamentally alter how we experience craving.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Can Ozempic End Addiction? | Dhruv Khullar | TED
To cite this card, link to https://intellectplus.co.uk/app/ideas-can-ozempic-end-addiction-dhruv-khullar.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
